Alrizomadlin
Product Specifications
CAS Number
1818393-16-6
Target
MDM-2/p53, E1/E2/E3 Enzyme, Mdm2, Apoptosis
Related Pathways
Apoptosis, Ubiquitination
Purity
0.9947
Bioactivity
Alrizomadlin is an orally active MDM2 inhibitor. APG-115 shows significant dose-dependent inhibitory effects on TP53wt AML cell lines. The IC50 values are 26.8 nM for MOLM-13 cells and 165.9 nM for MV-4-11 cells. , OCI-AML-3 cells 315.6 nM. Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell cycle arrest and apoptosis in a p53-dependent manner.
Smiles
CCN1[C@H]([C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc23)C11CCCCC1)C(=O)NC12CCC(CC1)(CC2)C(O)=O
Molecular Formula
C34H38Cl2FN3O4
Molecular Weight
642.59
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HNN-M701-1mg 1 mg
Monoclonal Anti-Mumps virus HN Antibody, Human IgG1 (7D12) (MALS verified)
Sign In for Pricing
View Details 124894-ML405 100 µL
CFDP1 (Craniofacial Development Protein 1, Bucentaur, BCNT) (MaxLight 405) discontinued
Sign In for Pricing
View Details KAC79867-01 100 mg
5- (3-Fluorophenyl) -1,2,4-oxadiazole-3-carboxylic acid
Sign In for Pricing
View Details KAC79867-02 1 g
5- (3-Fluorophenyl) -1,2,4-oxadiazole-3-carboxylic acid
Sign In for Pricing
View Details